Vascular Access Device Comprehensive Study by Type (Peripheral (Short, Midline), Central (Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted})), Application (Drug Administration, Fluid and Nutrition Administration, Blood Transfusion, Diagnostics and Testing), End User (Hospitals, Clinics, Ambulatory Care Centers, Diagnostic Centers) Players and Region - Global Market Outlook to 2026

Vascular Access Device Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Vascular Access Device Market Overview:
Venous access devices are the set devices ranging from peripheral IV cannula to central catheter used to access the arterial circulation. Vascular access devices are implanted into veins through peripheral or central vessels for the purpose of diagnosis making or therapeutic reasons. Central and peripheral are two major types of venous access devices. Central venous access devices are often referred to as venous access ports or catheters, because they permit frequent access to the veins deprived of deep needle sticks. Peripheral cannulae are the most commonly used type of venous access devices and are appropriate for short-term infusions of fluids, blood products, and medication.

Growth Drivers
  • Rising Number of Chemotherapy Processes
  • Growing Use of Vascular Access Devices in Pediatric Patients

Roadblocks
  • High Costs Related to the Placement and Maintenance of Vascular Access Devices
  • Stringent Rules and Regulations for Medical Devices

Opportunities
  • Increase in Examination and Clinical Trials for Vascular Access Devices

Challenges
  • Scarcity of Skilled Professionals
  • Risks Related to Vascular Access Devices


Competitive Landscape:

Some of the key players profiled in the report are C.R Bard (United States), B. Braun Melsungen AG (Germany), Cook Medical Inc. (United States), Teleflex, Inc. (United States), Smiths Medical (United States), Vygon U.S.A (United States), Romson Scientific (India), Prodimed (France), 3M. (United States), Bionic Medizintechnik GmbH (Germany) and Medtronic PLC (Ireland). Additionally, following companies can also be profiled that are part of our coverage like Biosensors International Group, Ltd (Singapore), Fresenius Medical Care Asia Pacific Limited (Hong Kong) and Edward Lifescience Corporation LLC (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Vascular Access Device market by 2026. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Vascular Access Device market.

Latest Market Insights:
On August 27, 2019 - Smiths Medical, a leading global medical device manufacturer, announced today it has partnered with Medline Industries for distribution of the Portex acapella choice vibratory PEP therapy device. This enhanced distribution partnership will be focused on the non-acute and home care channels.

What Can be Explored with the Vascular Access Device Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Vascular Access Device Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Vascular Access Device
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Vascular Access Device market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Vascular Access Device market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Venous Access Devices, Suppliers of Venous Access Devices, Wholesalers, Distributors and Retailers of Venous Access Devices, Healthcare Industry and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Peripheral [Short, Midline]
  • Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}]
By Application
  • Drug Administration
  • Fluid and Nutrition Administration
  • Blood Transfusion
  • Diagnostics and Testing
By End User
  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Diagnostic Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Chemotherapy Processes
      • 3.2.2. Growing Use of Vascular Access Devices in Pediatric Patients
    • 3.3. Market Challenges
      • 3.3.1. Scarcity of Skilled Professionals
      • 3.3.2. Risks Related to Vascular Access Devices
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Vascular Access Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vascular Access Device, by Type, Application, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Vascular Access Device (Value)
      • 5.2.1. Global Vascular Access Device by: Type (Value)
        • 5.2.1.1. Peripheral [Short, Midline]
        • 5.2.1.2. Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}]
      • 5.2.2. Global Vascular Access Device by: Application (Value)
        • 5.2.2.1. Drug Administration
        • 5.2.2.2. Fluid and Nutrition Administration
        • 5.2.2.3. Blood Transfusion
        • 5.2.2.4. Diagnostics and Testing
      • 5.2.3. Global Vascular Access Device by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory Care Centers
        • 5.2.3.4. Diagnostic Centers
      • 5.2.4. Global Vascular Access Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vascular Access Device (Volume)
      • 5.3.1. Global Vascular Access Device by: Type (Volume)
        • 5.3.1.1. Peripheral [Short, Midline]
        • 5.3.1.2. Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}]
      • 5.3.2. Global Vascular Access Device by: Application (Volume)
        • 5.3.2.1. Drug Administration
        • 5.3.2.2. Fluid and Nutrition Administration
        • 5.3.2.3. Blood Transfusion
        • 5.3.2.4. Diagnostics and Testing
      • 5.3.3. Global Vascular Access Device by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Ambulatory Care Centers
        • 5.3.3.4. Diagnostic Centers
      • 5.3.4. Global Vascular Access Device Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Vascular Access Device (Price)
      • 5.4.1. Global Vascular Access Device by: Type (Price)
  • 6. Vascular Access Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. C.R Bard (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. B. Braun Melsungen AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Medical Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teleflex, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Smiths Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vygon U.S.A (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Romson Scientific (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Prodimed (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. 3M. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bionic Medizintechnik GmbH (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Medtronic PLC (Ireland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Vascular Access Device Sale, by Type, Application, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Vascular Access Device (Value)
      • 7.2.1. Global Vascular Access Device by: Type (Value)
        • 7.2.1.1. Peripheral [Short, Midline]
        • 7.2.1.2. Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}]
      • 7.2.2. Global Vascular Access Device by: Application (Value)
        • 7.2.2.1. Drug Administration
        • 7.2.2.2. Fluid and Nutrition Administration
        • 7.2.2.3. Blood Transfusion
        • 7.2.2.4. Diagnostics and Testing
      • 7.2.3. Global Vascular Access Device by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory Care Centers
        • 7.2.3.4. Diagnostic Centers
      • 7.2.4. Global Vascular Access Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vascular Access Device (Volume)
      • 7.3.1. Global Vascular Access Device by: Type (Volume)
        • 7.3.1.1. Peripheral [Short, Midline]
        • 7.3.1.2. Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}]
      • 7.3.2. Global Vascular Access Device by: Application (Volume)
        • 7.3.2.1. Drug Administration
        • 7.3.2.2. Fluid and Nutrition Administration
        • 7.3.2.3. Blood Transfusion
        • 7.3.2.4. Diagnostics and Testing
      • 7.3.3. Global Vascular Access Device by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Ambulatory Care Centers
        • 7.3.3.4. Diagnostic Centers
      • 7.3.4. Global Vascular Access Device Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Vascular Access Device (Price)
      • 7.4.1. Global Vascular Access Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vascular Access Device: by Type(USD Million)
  • Table 2. Vascular Access Device Peripheral [Short, Midline] , by Region USD Million (2015-2020)
  • Table 3. Vascular Access Device Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}] , by Region USD Million (2015-2020)
  • Table 4. Vascular Access Device: by Application(USD Million)
  • Table 5. Vascular Access Device Drug Administration , by Region USD Million (2015-2020)
  • Table 6. Vascular Access Device Fluid and Nutrition Administration , by Region USD Million (2015-2020)
  • Table 7. Vascular Access Device Blood Transfusion , by Region USD Million (2015-2020)
  • Table 8. Vascular Access Device Diagnostics and Testing , by Region USD Million (2015-2020)
  • Table 9. Vascular Access Device: by End User(USD Million)
  • Table 10. Vascular Access Device Hospitals , by Region USD Million (2015-2020)
  • Table 11. Vascular Access Device Clinics , by Region USD Million (2015-2020)
  • Table 12. Vascular Access Device Ambulatory Care Centers , by Region USD Million (2015-2020)
  • Table 13. Vascular Access Device Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 14. South America Vascular Access Device, by Country USD Million (2015-2020)
  • Table 15. South America Vascular Access Device, by Type USD Million (2015-2020)
  • Table 16. South America Vascular Access Device, by Application USD Million (2015-2020)
  • Table 17. South America Vascular Access Device, by End User USD Million (2015-2020)
  • Table 18. Brazil Vascular Access Device, by Type USD Million (2015-2020)
  • Table 19. Brazil Vascular Access Device, by Application USD Million (2015-2020)
  • Table 20. Brazil Vascular Access Device, by End User USD Million (2015-2020)
  • Table 21. Argentina Vascular Access Device, by Type USD Million (2015-2020)
  • Table 22. Argentina Vascular Access Device, by Application USD Million (2015-2020)
  • Table 23. Argentina Vascular Access Device, by End User USD Million (2015-2020)
  • Table 24. Rest of South America Vascular Access Device, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Vascular Access Device, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Vascular Access Device, by End User USD Million (2015-2020)
  • Table 27. Asia Pacific Vascular Access Device, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Vascular Access Device, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Vascular Access Device, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Vascular Access Device, by End User USD Million (2015-2020)
  • Table 31. China Vascular Access Device, by Type USD Million (2015-2020)
  • Table 32. China Vascular Access Device, by Application USD Million (2015-2020)
  • Table 33. China Vascular Access Device, by End User USD Million (2015-2020)
  • Table 34. Japan Vascular Access Device, by Type USD Million (2015-2020)
  • Table 35. Japan Vascular Access Device, by Application USD Million (2015-2020)
  • Table 36. Japan Vascular Access Device, by End User USD Million (2015-2020)
  • Table 37. India Vascular Access Device, by Type USD Million (2015-2020)
  • Table 38. India Vascular Access Device, by Application USD Million (2015-2020)
  • Table 39. India Vascular Access Device, by End User USD Million (2015-2020)
  • Table 40. South Korea Vascular Access Device, by Type USD Million (2015-2020)
  • Table 41. South Korea Vascular Access Device, by Application USD Million (2015-2020)
  • Table 42. South Korea Vascular Access Device, by End User USD Million (2015-2020)
  • Table 43. Taiwan Vascular Access Device, by Type USD Million (2015-2020)
  • Table 44. Taiwan Vascular Access Device, by Application USD Million (2015-2020)
  • Table 45. Taiwan Vascular Access Device, by End User USD Million (2015-2020)
  • Table 46. Australia Vascular Access Device, by Type USD Million (2015-2020)
  • Table 47. Australia Vascular Access Device, by Application USD Million (2015-2020)
  • Table 48. Australia Vascular Access Device, by End User USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Vascular Access Device, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Vascular Access Device, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Vascular Access Device, by End User USD Million (2015-2020)
  • Table 52. Europe Vascular Access Device, by Country USD Million (2015-2020)
  • Table 53. Europe Vascular Access Device, by Type USD Million (2015-2020)
  • Table 54. Europe Vascular Access Device, by Application USD Million (2015-2020)
  • Table 55. Europe Vascular Access Device, by End User USD Million (2015-2020)
  • Table 56. Germany Vascular Access Device, by Type USD Million (2015-2020)
  • Table 57. Germany Vascular Access Device, by Application USD Million (2015-2020)
  • Table 58. Germany Vascular Access Device, by End User USD Million (2015-2020)
  • Table 59. France Vascular Access Device, by Type USD Million (2015-2020)
  • Table 60. France Vascular Access Device, by Application USD Million (2015-2020)
  • Table 61. France Vascular Access Device, by End User USD Million (2015-2020)
  • Table 62. Italy Vascular Access Device, by Type USD Million (2015-2020)
  • Table 63. Italy Vascular Access Device, by Application USD Million (2015-2020)
  • Table 64. Italy Vascular Access Device, by End User USD Million (2015-2020)
  • Table 65. United Kingdom Vascular Access Device, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Vascular Access Device, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Vascular Access Device, by End User USD Million (2015-2020)
  • Table 68. Netherlands Vascular Access Device, by Type USD Million (2015-2020)
  • Table 69. Netherlands Vascular Access Device, by Application USD Million (2015-2020)
  • Table 70. Netherlands Vascular Access Device, by End User USD Million (2015-2020)
  • Table 71. Rest of Europe Vascular Access Device, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Vascular Access Device, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Vascular Access Device, by End User USD Million (2015-2020)
  • Table 74. MEA Vascular Access Device, by Country USD Million (2015-2020)
  • Table 75. MEA Vascular Access Device, by Type USD Million (2015-2020)
  • Table 76. MEA Vascular Access Device, by Application USD Million (2015-2020)
  • Table 77. MEA Vascular Access Device, by End User USD Million (2015-2020)
  • Table 78. Middle East Vascular Access Device, by Type USD Million (2015-2020)
  • Table 79. Middle East Vascular Access Device, by Application USD Million (2015-2020)
  • Table 80. Middle East Vascular Access Device, by End User USD Million (2015-2020)
  • Table 81. Africa Vascular Access Device, by Type USD Million (2015-2020)
  • Table 82. Africa Vascular Access Device, by Application USD Million (2015-2020)
  • Table 83. Africa Vascular Access Device, by End User USD Million (2015-2020)
  • Table 84. North America Vascular Access Device, by Country USD Million (2015-2020)
  • Table 85. North America Vascular Access Device, by Type USD Million (2015-2020)
  • Table 86. North America Vascular Access Device, by Application USD Million (2015-2020)
  • Table 87. North America Vascular Access Device, by End User USD Million (2015-2020)
  • Table 88. United States Vascular Access Device, by Type USD Million (2015-2020)
  • Table 89. United States Vascular Access Device, by Application USD Million (2015-2020)
  • Table 90. United States Vascular Access Device, by End User USD Million (2015-2020)
  • Table 91. Canada Vascular Access Device, by Type USD Million (2015-2020)
  • Table 92. Canada Vascular Access Device, by Application USD Million (2015-2020)
  • Table 93. Canada Vascular Access Device, by End User USD Million (2015-2020)
  • Table 94. Mexico Vascular Access Device, by Type USD Million (2015-2020)
  • Table 95. Mexico Vascular Access Device, by Application USD Million (2015-2020)
  • Table 96. Mexico Vascular Access Device, by End User USD Million (2015-2020)
  • Table 97. Vascular Access Device Sales: by Type(K Units)
  • Table 98. Vascular Access Device Sales Peripheral [Short, Midline] , by Region K Units (2015-2020)
  • Table 99. Vascular Access Device Sales Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}] , by Region K Units (2015-2020)
  • Table 100. Vascular Access Device Sales: by Application(K Units)
  • Table 101. Vascular Access Device Sales Drug Administration , by Region K Units (2015-2020)
  • Table 102. Vascular Access Device Sales Fluid and Nutrition Administration , by Region K Units (2015-2020)
  • Table 103. Vascular Access Device Sales Blood Transfusion , by Region K Units (2015-2020)
  • Table 104. Vascular Access Device Sales Diagnostics and Testing , by Region K Units (2015-2020)
  • Table 105. Vascular Access Device Sales: by End User(K Units)
  • Table 106. Vascular Access Device Sales Hospitals , by Region K Units (2015-2020)
  • Table 107. Vascular Access Device Sales Clinics , by Region K Units (2015-2020)
  • Table 108. Vascular Access Device Sales Ambulatory Care Centers , by Region K Units (2015-2020)
  • Table 109. Vascular Access Device Sales Diagnostic Centers , by Region K Units (2015-2020)
  • Table 110. South America Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 111. South America Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 112. South America Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 113. South America Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 114. Brazil Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 115. Brazil Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 116. Brazil Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 117. Argentina Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 118. Argentina Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 119. Argentina Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 120. Rest of South America Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 121. Rest of South America Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 122. Rest of South America Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 123. Asia Pacific Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 124. Asia Pacific Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 125. Asia Pacific Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 126. Asia Pacific Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 127. China Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 128. China Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 129. China Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 130. Japan Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 131. Japan Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 132. Japan Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 133. India Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 134. India Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 135. India Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 136. South Korea Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 137. South Korea Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 138. South Korea Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 139. Taiwan Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 140. Taiwan Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 141. Taiwan Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 142. Australia Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 143. Australia Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 144. Australia Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 146. Rest of Asia-Pacific Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 148. Europe Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 149. Europe Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 150. Europe Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 151. Europe Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 152. Germany Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 153. Germany Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 154. Germany Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 155. France Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 156. France Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 157. France Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 158. Italy Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 159. Italy Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 160. Italy Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 161. United Kingdom Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 162. United Kingdom Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 163. United Kingdom Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 164. Netherlands Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 165. Netherlands Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 166. Netherlands Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 167. Rest of Europe Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 168. Rest of Europe Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 169. Rest of Europe Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 170. MEA Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 171. MEA Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 172. MEA Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 173. MEA Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 174. Middle East Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 175. Middle East Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 176. Middle East Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 177. Africa Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 178. Africa Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 179. Africa Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 180. North America Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 181. North America Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 182. North America Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 183. North America Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 184. United States Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 185. United States Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 186. United States Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 187. Canada Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 188. Canada Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 189. Canada Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 190. Mexico Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 191. Mexico Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 192. Mexico Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 193. Vascular Access Device: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Vascular Access Device: by Type(USD Million)
  • Table 206. Vascular Access Device Peripheral [Short, Midline] , by Region USD Million (2021-2026)
  • Table 207. Vascular Access Device Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}] , by Region USD Million (2021-2026)
  • Table 208. Vascular Access Device: by Application(USD Million)
  • Table 209. Vascular Access Device Drug Administration , by Region USD Million (2021-2026)
  • Table 210. Vascular Access Device Fluid and Nutrition Administration , by Region USD Million (2021-2026)
  • Table 211. Vascular Access Device Blood Transfusion , by Region USD Million (2021-2026)
  • Table 212. Vascular Access Device Diagnostics and Testing , by Region USD Million (2021-2026)
  • Table 213. Vascular Access Device: by End User(USD Million)
  • Table 214. Vascular Access Device Hospitals , by Region USD Million (2021-2026)
  • Table 215. Vascular Access Device Clinics , by Region USD Million (2021-2026)
  • Table 216. Vascular Access Device Ambulatory Care Centers , by Region USD Million (2021-2026)
  • Table 217. Vascular Access Device Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 218. South America Vascular Access Device, by Country USD Million (2021-2026)
  • Table 219. South America Vascular Access Device, by Type USD Million (2021-2026)
  • Table 220. South America Vascular Access Device, by Application USD Million (2021-2026)
  • Table 221. South America Vascular Access Device, by End User USD Million (2021-2026)
  • Table 222. Brazil Vascular Access Device, by Type USD Million (2021-2026)
  • Table 223. Brazil Vascular Access Device, by Application USD Million (2021-2026)
  • Table 224. Brazil Vascular Access Device, by End User USD Million (2021-2026)
  • Table 225. Argentina Vascular Access Device, by Type USD Million (2021-2026)
  • Table 226. Argentina Vascular Access Device, by Application USD Million (2021-2026)
  • Table 227. Argentina Vascular Access Device, by End User USD Million (2021-2026)
  • Table 228. Rest of South America Vascular Access Device, by Type USD Million (2021-2026)
  • Table 229. Rest of South America Vascular Access Device, by Application USD Million (2021-2026)
  • Table 230. Rest of South America Vascular Access Device, by End User USD Million (2021-2026)
  • Table 231. Asia Pacific Vascular Access Device, by Country USD Million (2021-2026)
  • Table 232. Asia Pacific Vascular Access Device, by Type USD Million (2021-2026)
  • Table 233. Asia Pacific Vascular Access Device, by Application USD Million (2021-2026)
  • Table 234. Asia Pacific Vascular Access Device, by End User USD Million (2021-2026)
  • Table 235. China Vascular Access Device, by Type USD Million (2021-2026)
  • Table 236. China Vascular Access Device, by Application USD Million (2021-2026)
  • Table 237. China Vascular Access Device, by End User USD Million (2021-2026)
  • Table 238. Japan Vascular Access Device, by Type USD Million (2021-2026)
  • Table 239. Japan Vascular Access Device, by Application USD Million (2021-2026)
  • Table 240. Japan Vascular Access Device, by End User USD Million (2021-2026)
  • Table 241. India Vascular Access Device, by Type USD Million (2021-2026)
  • Table 242. India Vascular Access Device, by Application USD Million (2021-2026)
  • Table 243. India Vascular Access Device, by End User USD Million (2021-2026)
  • Table 244. South Korea Vascular Access Device, by Type USD Million (2021-2026)
  • Table 245. South Korea Vascular Access Device, by Application USD Million (2021-2026)
  • Table 246. South Korea Vascular Access Device, by End User USD Million (2021-2026)
  • Table 247. Taiwan Vascular Access Device, by Type USD Million (2021-2026)
  • Table 248. Taiwan Vascular Access Device, by Application USD Million (2021-2026)
  • Table 249. Taiwan Vascular Access Device, by End User USD Million (2021-2026)
  • Table 250. Australia Vascular Access Device, by Type USD Million (2021-2026)
  • Table 251. Australia Vascular Access Device, by Application USD Million (2021-2026)
  • Table 252. Australia Vascular Access Device, by End User USD Million (2021-2026)
  • Table 253. Rest of Asia-Pacific Vascular Access Device, by Type USD Million (2021-2026)
  • Table 254. Rest of Asia-Pacific Vascular Access Device, by Application USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Vascular Access Device, by End User USD Million (2021-2026)
  • Table 256. Europe Vascular Access Device, by Country USD Million (2021-2026)
  • Table 257. Europe Vascular Access Device, by Type USD Million (2021-2026)
  • Table 258. Europe Vascular Access Device, by Application USD Million (2021-2026)
  • Table 259. Europe Vascular Access Device, by End User USD Million (2021-2026)
  • Table 260. Germany Vascular Access Device, by Type USD Million (2021-2026)
  • Table 261. Germany Vascular Access Device, by Application USD Million (2021-2026)
  • Table 262. Germany Vascular Access Device, by End User USD Million (2021-2026)
  • Table 263. France Vascular Access Device, by Type USD Million (2021-2026)
  • Table 264. France Vascular Access Device, by Application USD Million (2021-2026)
  • Table 265. France Vascular Access Device, by End User USD Million (2021-2026)
  • Table 266. Italy Vascular Access Device, by Type USD Million (2021-2026)
  • Table 267. Italy Vascular Access Device, by Application USD Million (2021-2026)
  • Table 268. Italy Vascular Access Device, by End User USD Million (2021-2026)
  • Table 269. United Kingdom Vascular Access Device, by Type USD Million (2021-2026)
  • Table 270. United Kingdom Vascular Access Device, by Application USD Million (2021-2026)
  • Table 271. United Kingdom Vascular Access Device, by End User USD Million (2021-2026)
  • Table 272. Netherlands Vascular Access Device, by Type USD Million (2021-2026)
  • Table 273. Netherlands Vascular Access Device, by Application USD Million (2021-2026)
  • Table 274. Netherlands Vascular Access Device, by End User USD Million (2021-2026)
  • Table 275. Rest of Europe Vascular Access Device, by Type USD Million (2021-2026)
  • Table 276. Rest of Europe Vascular Access Device, by Application USD Million (2021-2026)
  • Table 277. Rest of Europe Vascular Access Device, by End User USD Million (2021-2026)
  • Table 278. MEA Vascular Access Device, by Country USD Million (2021-2026)
  • Table 279. MEA Vascular Access Device, by Type USD Million (2021-2026)
  • Table 280. MEA Vascular Access Device, by Application USD Million (2021-2026)
  • Table 281. MEA Vascular Access Device, by End User USD Million (2021-2026)
  • Table 282. Middle East Vascular Access Device, by Type USD Million (2021-2026)
  • Table 283. Middle East Vascular Access Device, by Application USD Million (2021-2026)
  • Table 284. Middle East Vascular Access Device, by End User USD Million (2021-2026)
  • Table 285. Africa Vascular Access Device, by Type USD Million (2021-2026)
  • Table 286. Africa Vascular Access Device, by Application USD Million (2021-2026)
  • Table 287. Africa Vascular Access Device, by End User USD Million (2021-2026)
  • Table 288. North America Vascular Access Device, by Country USD Million (2021-2026)
  • Table 289. North America Vascular Access Device, by Type USD Million (2021-2026)
  • Table 290. North America Vascular Access Device, by Application USD Million (2021-2026)
  • Table 291. North America Vascular Access Device, by End User USD Million (2021-2026)
  • Table 292. United States Vascular Access Device, by Type USD Million (2021-2026)
  • Table 293. United States Vascular Access Device, by Application USD Million (2021-2026)
  • Table 294. United States Vascular Access Device, by End User USD Million (2021-2026)
  • Table 295. Canada Vascular Access Device, by Type USD Million (2021-2026)
  • Table 296. Canada Vascular Access Device, by Application USD Million (2021-2026)
  • Table 297. Canada Vascular Access Device, by End User USD Million (2021-2026)
  • Table 298. Mexico Vascular Access Device, by Type USD Million (2021-2026)
  • Table 299. Mexico Vascular Access Device, by Application USD Million (2021-2026)
  • Table 300. Mexico Vascular Access Device, by End User USD Million (2021-2026)
  • Table 301. Vascular Access Device Sales: by Type(K Units)
  • Table 302. Vascular Access Device Sales Peripheral [Short, Midline] , by Region K Units (2021-2026)
  • Table 303. Vascular Access Device Sales Central [Peripherally Inserted Central Catheter, Central Venous Access Device {Non- tunnelled, Tunneled, Implanted}] , by Region K Units (2021-2026)
  • Table 304. Vascular Access Device Sales: by Application(K Units)
  • Table 305. Vascular Access Device Sales Drug Administration , by Region K Units (2021-2026)
  • Table 306. Vascular Access Device Sales Fluid and Nutrition Administration , by Region K Units (2021-2026)
  • Table 307. Vascular Access Device Sales Blood Transfusion , by Region K Units (2021-2026)
  • Table 308. Vascular Access Device Sales Diagnostics and Testing , by Region K Units (2021-2026)
  • Table 309. Vascular Access Device Sales: by End User(K Units)
  • Table 310. Vascular Access Device Sales Hospitals , by Region K Units (2021-2026)
  • Table 311. Vascular Access Device Sales Clinics , by Region K Units (2021-2026)
  • Table 312. Vascular Access Device Sales Ambulatory Care Centers , by Region K Units (2021-2026)
  • Table 313. Vascular Access Device Sales Diagnostic Centers , by Region K Units (2021-2026)
  • Table 314. South America Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 315. South America Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 316. South America Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 317. South America Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 318. Brazil Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 319. Brazil Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 320. Brazil Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 321. Argentina Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 322. Argentina Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 323. Argentina Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 324. Rest of South America Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 325. Rest of South America Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 326. Rest of South America Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 327. Asia Pacific Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 328. Asia Pacific Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 329. Asia Pacific Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 330. Asia Pacific Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 331. China Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 332. China Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 333. China Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 334. Japan Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 335. Japan Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 336. Japan Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 337. India Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 338. India Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 339. India Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 340. South Korea Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 341. South Korea Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 342. South Korea Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 343. Taiwan Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 344. Taiwan Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 345. Taiwan Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 346. Australia Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 347. Australia Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 348. Australia Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 349. Rest of Asia-Pacific Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 350. Rest of Asia-Pacific Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 351. Rest of Asia-Pacific Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 352. Europe Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 353. Europe Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 354. Europe Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 355. Europe Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 356. Germany Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 357. Germany Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 358. Germany Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 359. France Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 360. France Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 361. France Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 362. Italy Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 363. Italy Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 364. Italy Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 365. United Kingdom Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 366. United Kingdom Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 367. United Kingdom Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 368. Netherlands Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 369. Netherlands Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 370. Netherlands Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 371. Rest of Europe Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 372. Rest of Europe Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 373. Rest of Europe Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 374. MEA Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 375. MEA Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 376. MEA Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 377. MEA Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 378. Middle East Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 379. Middle East Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 380. Middle East Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 381. Africa Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 382. Africa Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 383. Africa Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 384. North America Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 385. North America Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 386. North America Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 387. North America Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 388. United States Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 389. United States Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 390. United States Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 391. Canada Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 392. Canada Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 393. Canada Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 394. Mexico Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 395. Mexico Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 396. Mexico Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 397. Vascular Access Device: by Type(USD/Units)
  • Table 398. Research Programs/Design for This Report
  • Table 399. Key Data Information from Secondary Sources
  • Table 400. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vascular Access Device: by Type USD Million (2015-2020)
  • Figure 5. Global Vascular Access Device: by Application USD Million (2015-2020)
  • Figure 6. Global Vascular Access Device: by End User USD Million (2015-2020)
  • Figure 7. South America Vascular Access Device Share (%), by Country
  • Figure 8. Asia Pacific Vascular Access Device Share (%), by Country
  • Figure 9. Europe Vascular Access Device Share (%), by Country
  • Figure 10. MEA Vascular Access Device Share (%), by Country
  • Figure 11. North America Vascular Access Device Share (%), by Country
  • Figure 12. Global Vascular Access Device: by Type K Units (2015-2020)
  • Figure 13. Global Vascular Access Device: by Application K Units (2015-2020)
  • Figure 14. Global Vascular Access Device: by End User K Units (2015-2020)
  • Figure 15. South America Vascular Access Device Share (%), by Country
  • Figure 16. Asia Pacific Vascular Access Device Share (%), by Country
  • Figure 17. Europe Vascular Access Device Share (%), by Country
  • Figure 18. MEA Vascular Access Device Share (%), by Country
  • Figure 19. North America Vascular Access Device Share (%), by Country
  • Figure 20. Global Vascular Access Device: by Type USD/Units (2015-2020)
  • Figure 21. Global Vascular Access Device share by Players 2020 (%)
  • Figure 22. Global Vascular Access Device share by Players (Top 3) 2020(%)
  • Figure 23. Global Vascular Access Device share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. C.R Bard (United States) Revenue, Net Income and Gross profit
  • Figure 26. C.R Bard (United States) Revenue: by Geography 2020
  • Figure 27. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 29. Cook Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cook Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Teleflex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Teleflex, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Smiths Medical (United States) Revenue: by Geography 2020
  • Figure 35. Vygon U.S.A (United States) Revenue, Net Income and Gross profit
  • Figure 36. Vygon U.S.A (United States) Revenue: by Geography 2020
  • Figure 37. Romson Scientific (India) Revenue, Net Income and Gross profit
  • Figure 38. Romson Scientific (India) Revenue: by Geography 2020
  • Figure 39. Prodimed (France) Revenue, Net Income and Gross profit
  • Figure 40. Prodimed (France) Revenue: by Geography 2020
  • Figure 41. 3M. (United States) Revenue, Net Income and Gross profit
  • Figure 42. 3M. (United States) Revenue: by Geography 2020
  • Figure 43. Bionic Medizintechnik GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Bionic Medizintechnik GmbH (Germany) Revenue: by Geography 2020
  • Figure 45. Medtronic PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 46. Medtronic PLC (Ireland) Revenue: by Geography 2020
  • Figure 47. Global Vascular Access Device: by Type USD Million (2021-2026)
  • Figure 48. Global Vascular Access Device: by Application USD Million (2021-2026)
  • Figure 49. Global Vascular Access Device: by End User USD Million (2021-2026)
  • Figure 50. South America Vascular Access Device Share (%), by Country
  • Figure 51. Asia Pacific Vascular Access Device Share (%), by Country
  • Figure 52. Europe Vascular Access Device Share (%), by Country
  • Figure 53. MEA Vascular Access Device Share (%), by Country
  • Figure 54. North America Vascular Access Device Share (%), by Country
  • Figure 55. Global Vascular Access Device: by Type K Units (2021-2026)
  • Figure 56. Global Vascular Access Device: by Application K Units (2021-2026)
  • Figure 57. Global Vascular Access Device: by End User K Units (2021-2026)
  • Figure 58. South America Vascular Access Device Share (%), by Country
  • Figure 59. Asia Pacific Vascular Access Device Share (%), by Country
  • Figure 60. Europe Vascular Access Device Share (%), by Country
  • Figure 61. MEA Vascular Access Device Share (%), by Country
  • Figure 62. North America Vascular Access Device Share (%), by Country
  • Figure 63. Global Vascular Access Device: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • C.R Bard (United States)
  • B. Braun Melsungen AG (Germany)
  • Cook Medical Inc. (United States)
  • Teleflex, Inc. (United States)
  • Smiths Medical (United States)
  • Vygon U.S.A (United States)
  • Romson Scientific (India)
  • Prodimed (France)
  • 3M. (United States)
  • Bionic Medizintechnik GmbH (Germany)
  • Medtronic PLC (Ireland)
Additional players considered in the study are as follows:
Biosensors International Group, Ltd (Singapore) , Fresenius Medical Care Asia Pacific Limited (Hong Kong) , Edward Lifescience Corporation LLC (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 210 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Vascular Access Device market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Vascular Access Device market are C.R Bard (United States), B. Braun Melsungen AG (Germany), Cook Medical Inc. (United States), Teleflex, Inc. (United States), Smiths Medical (United States), Vygon U.S.A (United States), Romson Scientific (India), Prodimed (France), 3M. (United States), Bionic Medizintechnik GmbH (Germany) and Medtronic PLC (Ireland), to name a few.
"Technological Advancements in Vascular Access Devices" is seen as one of major influencing trends for Vascular Access Device Market during projected period 2020-2026.

Know More About Global Vascular Access Device Report?